Abstract
The complex inheritance involved in multiple sclerosis (MS) risk has been extensively investigated, but our understanding of MS genetics remains rudimentary. In this study, we explore 51 single nucleotide polymorphisms (SNPs) in 36 candidate genes from the inflammatory pathway and test for gene–gene interactions using complementary case–control, discordant sibling pair, and trio family study designs. We used a sample of 421 carefully diagnosed MS cases and 96 unrelated, healthy controls; discordant sibling pairs from 146 multiplex families; and 275 trio families. We used multifactor dimensionality reduction to explore gene–gene interactions. Based on our analyses, we have identified several statistically significant models including both main effect models and two-locus, three-locus, and four-locus epistasis models that predict MS disease risk with between ∼61% and 85% accuracy. These results suggest that significant epistasis, or gene–gene interactions, may exist even in the absence of statistically significant individual main effects.
Similar content being viewed by others
References
Hauser SL, Goodin DS (2005) Multiple sclerosis and other demyelinating diseases. In: Kasper DL, Braunwalk E, Fauci AD, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principle of internal medicine, 16th edn. McGraw-Hill, New York
Oksenberg JR, Barcellos LF (2005) Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 6:375–387
Ebers G (1999) Modelling multiple sclerosis. Nat Genet 23:258–259
Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469–471
Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER et al (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 7:1229–1234
Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR, Hauser SL et al (2006) Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44. Genes Immun 7:73–76
Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J et al (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464–468
Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A et al (2005) A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 77:454–467
Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S et al (2002) Genetic basis for clinical expression in multiple sclerosis. Brain 125:150–158
Bellman R (1961) Adaptive control processes. Princeton University Press, Princeton
Concato J, Feinstein AR, Holford TR (1993) The risk of determining risk with multivariable models. Ann Intern Med 118:201–210
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373–1379
Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF et al (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138–147
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E et al (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710–716
Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene–gene and gene–environment interactions. Bioinformatics 19:376–382
Ritchie MD, Hahn LW, Moore JH (2003) Power of multifactor dimensionality reduction for detecting gene–gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24:150–157
Japkowicz N, Stephen S (2002) The class imbalance problem: a systematic study. Intelligent Data Analysis 6:429–450
Weiss GM, Provost F (2003) Learning when training data are costly: the effect of class distribution on tree induction. J Artif Intell Res 19:315–354
McDonnell GV, Kirk CW, Hawkins SA, Graham CA (2000) An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J Neurol Sci 176:4–12
Reboul J, Mertens C, Levillayer F, Eichenbaum-Voline S, Vilkoren T, Cournu I et al (2000) Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group. J Neuroimmunol 102:107–112
Vandenbroeck K, Martino G, Marrosu M, Consiglio A, Zaffaroni M, Vaccargiu S et al (1997) Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol 76:189–192
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S et al (2004) Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 55:793–800
Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P (2005) A haplotype map of the human genome. Nature 437:1299–1320
Candelaria PV, Backer V, Laing IA, Porsbjerg C, Nepper-Christensen S, de Klerk N et al (2005) Association between asthma-related phenotypes and the CC16 A38G polymorphism in an unselected population of young adult Danes. Immunogenetics 57:25–32
Menegatti E, Nardacchione A, Alpa M, Agnes C, Rossi D, Chiara M et al (2002) Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy. Lab Invest 82:543–546
Ohchi T, Shijubo N, Kawabata I, Ichimiya S, Inomata S, Yamaguchi A et al (2004) Polymorphism of Clara cell 10-kD protein gene of sarcoidosis. Am J Respir Crit Care Med 169:180–186
Ray R, Choi M, Zhang Z, Silverman GA, Askew D, Mukherjee AB (2005) Uteroglobin suppresses SCCA gene expression associated with allergic asthma. J Biol Chem 280:9761–9764
Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG et al (2004) Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 50:43–54
Hung CH, Chen LC, Zhang Z, Chowdhury B, Lee WL, Plunkett B et al (2004) Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein. J Allergy Clin Immunol 114:664–670
Zhang Z, Kundu GC, Zheng F, Yuan CJ, Lee E, Westphal H et al (2000) Insight into the physiological function(s) of uteroglobin by gene-knockout and antisense-transgenic approaches. Ann N Y Acad Sci 923:210–233
Lucchinetti CF, Parisi J, Bruck W (2005) The pathology of multiple sclerosis. Neurol Clin 23:77–105, vi
Zhang Y, Da RR, Hilgenberg LG, Tourtellotte WW, Sobel RA, Smith MA et al (2005) Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol 167:120–130
Loza MJ, Foster S, Peters SP, Penn RB (2006) Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood 107:2052–2060
Loop T, Bross T, Humar M, Hoetzel A, Schmidt R, Pahl HL et al (2004) Dobutamine inhibits phorbol–myristate–acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro. Anesth Analg 99:1508–1515
Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B et al (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell 14:303–317
Chorley BN, Li Y, Fang S, Park JA, Adler KB (2006) (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol 34:119–127
Martin ER, Ritchie MD, Hahn LW, Kang S, Moore JH (2005) A novel method to identify gene–gene effects in nuclear families: the MDR-PDT. Genet Epidemiol (in press)
Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL et al (2006) Multifactor dimensionality reduction reveals gene–gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun 7:310–315
Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A et al (2005) A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 37:1113–1118
Templeton A (2000) Epistasis and complex traits. In: Wade M, Broadie B III, Wolf J (eds) Epistasis and the evolutionary process. Oxford University Press, Oxford, pp 41–57
Acknowledgments
We are grateful to the MS patients and their families for participating in this study. This work was funded by grants RG2901 from the National Multiple Sclerosis Society and by National Institutes of Health grants NS026799, GM31304, AG20135, GM62758, NS32830, and in part by HL65962, the Pharmacogenomics of Arrhythmia Therapy U01 site of the Pharmacogenetics Research Network.
Author information
Authors and Affiliations
Corresponding author
Additional information
Alison A. Motsinger and David Brassat contributed equally to this work.
Rights and permissions
About this article
Cite this article
Motsinger, A.A., Brassat, D., Caillier, S.J. et al. Complex gene–gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics 8, 11–20 (2007). https://doi.org/10.1007/s10048-006-0058-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-006-0058-9